Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Caitlin Driscoll"'
Autor:
Fidel Rubagumya, Mary Jue Xu, Leana May, Caitlin Driscoll, Frank Regis Uwizeye, Cyprien Shyirambere, Katherine Larrabee, Alexandra E. Fehr, Umuhizi Denis Gilbert, Clemence Muhayimana, Vedaste Hategekimana, Shekinah Elmore, Tharcisse Mpunga, Molly Moore, Lawrence N. Shulman, Leslie Lehmann
Publikováno v:
Journal of Global Oncology, Vol 4, Pp 1-11 (2017)
Purpose: Children with acute lymphoblastic leukemia (ALL) in low-income countries have disproportionately lower cure rates than those in high-income countries. At Butaro Cancer Center of Excellence (BCCOE), physicians treated patients with ALL with t
Externí odkaz:
https://doaj.org/article/247c33e0ec394c978f7c34f177f8d024
Autor:
Justine, Seidenfeld, Caitlin, Driscoll, Laura, Germino, Elissa, Nickolopoulos, Valerie, Keck, Jan, Dillard, Gregory, Brown, Lynn, Bowlby, Alex, Cho
Publikováno v:
Journal of Interprofessional Care. 37:160-163
This article describes the Highly Individualized Dedicated Onsite Care (HIDOC) intensive primary care program implemented at a university clinic, comprising (a) care by an interprofessional team, (b) new logistical capacity, and (c) clinician skills
Autor:
Deogratias Ruhangaza, Alan Paciorek, Tharcisse Mpunga, Leslie Lehmann, Lawrence N. Shulman, Temidayo Fadelu, Paul H. Park, Jean Bosco Bigirimana, Yvan Butera, Caitlin Driscoll, Cyprien Shyirambere, Cam Nguyen, Aline Umwizerwa, Rebecca DeBoer, Clemence Muhayimana
Publikováno v:
JCO Global Oncology
PURPOSE Hodgkin lymphoma (HL) is highly curable in high-income countries (HICs), yet many patients around the world do not have access to therapy. In 2012, cancer care was established at a rural district hospital in Rwanda through international colla
Autor:
Mary Jue Xu, Clemence Muhayimana, Vedaste Hategekimana, Leana May, Tharcisse Mpunga, Shekinah N. Elmore, Molly Moore, Caitlin Driscoll, Umuhizi Denis Gilbert, Fidel Rubagumya, Alexandra E. Fehr, Katherine Larrabee, Frank Regis Uwizeye, Leslie Lehmann, Cyprien Shyirambere, Lawrence N. Shulman
Publikováno v:
Journal of Global Oncology, Vol 4, Pp 1-11 (2017)
Journal of Global Oncology
Journal of global oncology, vol 4, iss 4
Journal of Global Oncology
Journal of global oncology, vol 4, iss 4
Purpose Children with acute lymphoblastic leukemia (ALL) in low-income countries have disproportionately lower cure rates than those in high-income countries. At Butaro Cancer Center of Excellence (BCCOE), physicians treated patients with ALL with th
Autor:
Neo Tapela, Leslie Lehmann, Vedaste Hategekimana, Temidayo Fadelu, Leana May, Ignace Nzayisenga, Denis Gilbert Umuhizi, Shekinah N. Elmore, Clemence Muhayimana, Caitlin Driscoll, Frank Regis Uwizeye, Cyprien Shyirambere, Mary Jue Xu, Fidel Rubagumya, Lawrence N. Shulman, Tharcisse Mpunga
Publikováno v:
Journal of Global Oncology
Purpose Success in treating nephroblastoma in high-income countries has been transferred to some resource-constrained settings; multicenter studies report disease-free survival of greater than 70%. However, few reports present care models with rural-
Autor:
Lydia E. Pace, Lawrence N. Shulman, Denis Gilbert Umuhizi, Leslie Lehmann, Neo Tapela, Vedaste Hategekimana, Bethany Hedt-Gauthier, Jean Bosco Bigirimana, Cyprien Shyirambere, Tharcisse Mpunga, JingJing Wang, Clemence Muhayimana, Ignace Nzayisenga, Gedeon Ngoga, Frank Regis Uwizeye, Peter Drobac, Caitlin Driscoll, Egide Mpanumusingo, Molly Moore, Mary Jue Xu
Publikováno v:
BMC Cancer
Background Cancer services are inaccessible in many low-income countries, and few published examples describe oncology programs within the public sector. In 2011, the Rwanda Ministry of Health (RMOH) established Butaro Cancer Center of Excellence (BC
Autor:
Yvan Butera, Rebecca DeBoer, Cyprien Shyirambere, Paul H. Park, Caitlin Driscoll, Francois Regis Uwizeye, Leslie Lehmann, Lawrence N. Shulman, Temidayo Fadelu, Jean Bosco Bigirimana, Alan Paciorek
Publikováno v:
Journal of Global Oncology. 2:67s-67s
Background: While Hodgkin lymphoma (HL) is highly curable with standard chemotherapy in high-resource settings, there are few reports of HL treatment in low-resource settings. In Rwanda, a treatment protocol using six cycles of ABVD chemotherapy (dox
Autor:
Philip C. Amrein, Steven L. McAfee, Suiyang Liu, David Avigan, Caitlin Driscoll, Edward A. Fox, Richard Stone, Eyal C. Attar, David P. Steensma, James D. Griffin, Karen K. Ballen, Daniel J. DeAngelo, Ilene Galinsky, Martha Wadleigh
Publikováno v:
Blood. 120:3627-3627
Abstract 3627 Background: In pts with mutant FLT3 AML single agent studies with inhibitors of FLT3, such as midostaurin, yielded a high rate of peripheral blast reduction but complete and partial remissions were uncommon. One approach to overcome res
Autor:
Rubagumya F; Fidel Rubagumya, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania; Mary Jue Xu, University of California, San Francisco, San Francisco, CA; Leana May, Children's Hospital Colorado, Aurora, CO; Caitlin Driscoll, Mount Sinai Medical School, New York, NY; Frank Regis Uwizeye, Cyprien Shyirambere, and Alexandra E. Fehr, Inshuti Mu Buzima/Partners In Health; Umuhizi Denis Gilbert, Clemence Muhayimana, Vedaste Hategekimana, and Tharcisse Mpunga, Ministry of Health, Kigali, Rwanda; Katherine Larrabee, Geisinger Commonwealth School of Medicine, Scranton; Lawrence N. Shulman, University of Pennsylvania, Philadelphia, PA; Shekinah Elmore, Harvard Radiation Oncology Program; Leslie Lehmann, Dana Farber Cancer Institute; Boston Children's Hospital, Boston, MA; and Molly Moore, University of Vermont, Burlington, VT., Xu MJ; Fidel Rubagumya, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania; Mary Jue Xu, University of California, San Francisco, San Francisco, CA; Leana May, Children's Hospital Colorado, Aurora, CO; Caitlin Driscoll, Mount Sinai Medical School, New York, NY; Frank Regis Uwizeye, Cyprien Shyirambere, and Alexandra E. Fehr, Inshuti Mu Buzima/Partners In Health; Umuhizi Denis Gilbert, Clemence Muhayimana, Vedaste Hategekimana, and Tharcisse Mpunga, Ministry of Health, Kigali, Rwanda; Katherine Larrabee, Geisinger Commonwealth School of Medicine, Scranton; Lawrence N. Shulman, University of Pennsylvania, Philadelphia, PA; Shekinah Elmore, Harvard Radiation Oncology Program; Leslie Lehmann, Dana Farber Cancer Institute; Boston Children's Hospital, Boston, MA; and Molly Moore, University of Vermont, Burlington, VT., May L; Fidel Rubagumya, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania; Mary Jue Xu, University of California, San Francisco, San Francisco, CA; Leana May, Children's Hospital Colorado, Aurora, CO; Caitlin Driscoll, Mount Sinai Medical School, New York, NY; Frank Regis Uwizeye, Cyprien Shyirambere, and Alexandra E. Fehr, Inshuti Mu Buzima/Partners In Health; Umuhizi Denis Gilbert, Clemence Muhayimana, Vedaste Hategekimana, and Tharcisse Mpunga, Ministry of Health, Kigali, Rwanda; Katherine Larrabee, Geisinger Commonwealth School of Medicine, Scranton; Lawrence N. Shulman, University of Pennsylvania, Philadelphia, PA; Shekinah Elmore, Harvard Radiation Oncology Program; Leslie Lehmann, Dana Farber Cancer Institute; Boston Children's Hospital, Boston, MA; and Molly Moore, University of Vermont, Burlington, VT., Driscoll C; Fidel Rubagumya, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania; Mary Jue Xu, University of California, San Francisco, San Francisco, CA; Leana May, Children's Hospital Colorado, Aurora, CO; Caitlin Driscoll, Mount Sinai Medical School, New York, NY; Frank Regis Uwizeye, Cyprien Shyirambere, and Alexandra E. Fehr, Inshuti Mu Buzima/Partners In Health; Umuhizi Denis Gilbert, Clemence Muhayimana, Vedaste Hategekimana, and Tharcisse Mpunga, Ministry of Health, Kigali, Rwanda; Katherine Larrabee, Geisinger Commonwealth School of Medicine, Scranton; Lawrence N. Shulman, University of Pennsylvania, Philadelphia, PA; Shekinah Elmore, Harvard Radiation Oncology Program; Leslie Lehmann, Dana Farber Cancer Institute; Boston Children's Hospital, Boston, MA; and Molly Moore, University of Vermont, Burlington, VT., Uwizeye FR; Fidel Rubagumya, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania; Mary Jue Xu, University of California, San Francisco, San Francisco, CA; Leana May, Children's Hospital Colorado, Aurora, CO; Caitlin Driscoll, Mount Sinai Medical School, New York, NY; Frank Regis Uwizeye, Cyprien Shyirambere, and Alexandra E. Fehr, Inshuti Mu Buzima/Partners In Health; Umuhizi Denis Gilbert, Clemence Muhayimana, Vedaste Hategekimana, and Tharcisse Mpunga, Ministry of Health, Kigali, Rwanda; Katherine Larrabee, Geisinger Commonwealth School of Medicine, Scranton; Lawrence N. Shulman, University of Pennsylvania, Philadelphia, PA; Shekinah Elmore, Harvard Radiation Oncology Program; Leslie Lehmann, Dana Farber Cancer Institute; Boston Children's Hospital, Boston, MA; and Molly Moore, University of Vermont, Burlington, VT., Shyirambere C; Fidel Rubagumya, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania; Mary Jue Xu, University of California, San Francisco, San Francisco, CA; Leana May, Children's Hospital Colorado, Aurora, CO; Caitlin Driscoll, Mount Sinai Medical School, New York, NY; Frank Regis Uwizeye, Cyprien Shyirambere, and Alexandra E. Fehr, Inshuti Mu Buzima/Partners In Health; Umuhizi Denis Gilbert, Clemence Muhayimana, Vedaste Hategekimana, and Tharcisse Mpunga, Ministry of Health, Kigali, Rwanda; Katherine Larrabee, Geisinger Commonwealth School of Medicine, Scranton; Lawrence N. Shulman, University of Pennsylvania, Philadelphia, PA; Shekinah Elmore, Harvard Radiation Oncology Program; Leslie Lehmann, Dana Farber Cancer Institute; Boston Children's Hospital, Boston, MA; and Molly Moore, University of Vermont, Burlington, VT., Larrabee K; Fidel Rubagumya, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania; Mary Jue Xu, University of California, San Francisco, San Francisco, CA; Leana May, Children's Hospital Colorado, Aurora, CO; Caitlin Driscoll, Mount Sinai Medical School, New York, NY; Frank Regis Uwizeye, Cyprien Shyirambere, and Alexandra E. Fehr, Inshuti Mu Buzima/Partners In Health; Umuhizi Denis Gilbert, Clemence Muhayimana, Vedaste Hategekimana, and Tharcisse Mpunga, Ministry of Health, Kigali, Rwanda; Katherine Larrabee, Geisinger Commonwealth School of Medicine, Scranton; Lawrence N. Shulman, University of Pennsylvania, Philadelphia, PA; Shekinah Elmore, Harvard Radiation Oncology Program; Leslie Lehmann, Dana Farber Cancer Institute; Boston Children's Hospital, Boston, MA; and Molly Moore, University of Vermont, Burlington, VT., Fehr AE; Fidel Rubagumya, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania; Mary Jue Xu, University of California, San Francisco, San Francisco, CA; Leana May, Children's Hospital Colorado, Aurora, CO; Caitlin Driscoll, Mount Sinai Medical School, New York, NY; Frank Regis Uwizeye, Cyprien Shyirambere, and Alexandra E. Fehr, Inshuti Mu Buzima/Partners In Health; Umuhizi Denis Gilbert, Clemence Muhayimana, Vedaste Hategekimana, and Tharcisse Mpunga, Ministry of Health, Kigali, Rwanda; Katherine Larrabee, Geisinger Commonwealth School of Medicine, Scranton; Lawrence N. Shulman, University of Pennsylvania, Philadelphia, PA; Shekinah Elmore, Harvard Radiation Oncology Program; Leslie Lehmann, Dana Farber Cancer Institute; Boston Children's Hospital, Boston, MA; and Molly Moore, University of Vermont, Burlington, VT., Gilbert UD; Fidel Rubagumya, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania; Mary Jue Xu, University of California, San Francisco, San Francisco, CA; Leana May, Children's Hospital Colorado, Aurora, CO; Caitlin Driscoll, Mount Sinai Medical School, New York, NY; Frank Regis Uwizeye, Cyprien Shyirambere, and Alexandra E. Fehr, Inshuti Mu Buzima/Partners In Health; Umuhizi Denis Gilbert, Clemence Muhayimana, Vedaste Hategekimana, and Tharcisse Mpunga, Ministry of Health, Kigali, Rwanda; Katherine Larrabee, Geisinger Commonwealth School of Medicine, Scranton; Lawrence N. Shulman, University of Pennsylvania, Philadelphia, PA; Shekinah Elmore, Harvard Radiation Oncology Program; Leslie Lehmann, Dana Farber Cancer Institute; Boston Children's Hospital, Boston, MA; and Molly Moore, University of Vermont, Burlington, VT., Muhayimana C; Fidel Rubagumya, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania; Mary Jue Xu, University of California, San Francisco, San Francisco, CA; Leana May, Children's Hospital Colorado, Aurora, CO; Caitlin Driscoll, Mount Sinai Medical School, New York, NY; Frank Regis Uwizeye, Cyprien Shyirambere, and Alexandra E. Fehr, Inshuti Mu Buzima/Partners In Health; Umuhizi Denis Gilbert, Clemence Muhayimana, Vedaste Hategekimana, and Tharcisse Mpunga, Ministry of Health, Kigali, Rwanda; Katherine Larrabee, Geisinger Commonwealth School of Medicine, Scranton; Lawrence N. Shulman, University of Pennsylvania, Philadelphia, PA; Shekinah Elmore, Harvard Radiation Oncology Program; Leslie Lehmann, Dana Farber Cancer Institute; Boston Children's Hospital, Boston, MA; and Molly Moore, University of Vermont, Burlington, VT., Hategekimana V; Fidel Rubagumya, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania; Mary Jue Xu, University of California, San Francisco, San Francisco, CA; Leana May, Children's Hospital Colorado, Aurora, CO; Caitlin Driscoll, Mount Sinai Medical School, New York, NY; Frank Regis Uwizeye, Cyprien Shyirambere, and Alexandra E. Fehr, Inshuti Mu Buzima/Partners In Health; Umuhizi Denis Gilbert, Clemence Muhayimana, Vedaste Hategekimana, and Tharcisse Mpunga, Ministry of Health, Kigali, Rwanda; Katherine Larrabee, Geisinger Commonwealth School of Medicine, Scranton; Lawrence N. Shulman, University of Pennsylvania, Philadelphia, PA; Shekinah Elmore, Harvard Radiation Oncology Program; Leslie Lehmann, Dana Farber Cancer Institute; Boston Children's Hospital, Boston, MA; and Molly Moore, University of Vermont, Burlington, VT., Elmore S; Fidel Rubagumya, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania; Mary Jue Xu, University of California, San Francisco, San Francisco, CA; Leana May, Children's Hospital Colorado, Aurora, CO; Caitlin Driscoll, Mount Sinai Medical School, New York, NY; Frank Regis Uwizeye, Cyprien Shyirambere, and Alexandra E. Fehr, Inshuti Mu Buzima/Partners In Health; Umuhizi Denis Gilbert, Clemence Muhayimana, Vedaste Hategekimana, and Tharcisse Mpunga, Ministry of Health, Kigali, Rwanda; Katherine Larrabee, Geisinger Commonwealth School of Medicine, Scranton; Lawrence N. Shulman, University of Pennsylvania, Philadelphia, PA; Shekinah Elmore, Harvard Radiation Oncology Program; Leslie Lehmann, Dana Farber Cancer Institute; Boston Children's Hospital, Boston, MA; and Molly Moore, University of Vermont, Burlington, VT., Mpunga T; Fidel Rubagumya, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania; Mary Jue Xu, University of California, San Francisco, San Francisco, CA; Leana May, Children's Hospital Colorado, Aurora, CO; Caitlin Driscoll, Mount Sinai Medical School, New York, NY; Frank Regis Uwizeye, Cyprien Shyirambere, and Alexandra E. Fehr, Inshuti Mu Buzima/Partners In Health; Umuhizi Denis Gilbert, Clemence Muhayimana, Vedaste Hategekimana, and Tharcisse Mpunga, Ministry of Health, Kigali, Rwanda; Katherine Larrabee, Geisinger Commonwealth School of Medicine, Scranton; Lawrence N. Shulman, University of Pennsylvania, Philadelphia, PA; Shekinah Elmore, Harvard Radiation Oncology Program; Leslie Lehmann, Dana Farber Cancer Institute; Boston Children's Hospital, Boston, MA; and Molly Moore, University of Vermont, Burlington, VT., Moore M; Fidel Rubagumya, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania; Mary Jue Xu, University of California, San Francisco, San Francisco, CA; Leana May, Children's Hospital Colorado, Aurora, CO; Caitlin Driscoll, Mount Sinai Medical School, New York, NY; Frank Regis Uwizeye, Cyprien Shyirambere, and Alexandra E. Fehr, Inshuti Mu Buzima/Partners In Health; Umuhizi Denis Gilbert, Clemence Muhayimana, Vedaste Hategekimana, and Tharcisse Mpunga, Ministry of Health, Kigali, Rwanda; Katherine Larrabee, Geisinger Commonwealth School of Medicine, Scranton; Lawrence N. Shulman, University of Pennsylvania, Philadelphia, PA; Shekinah Elmore, Harvard Radiation Oncology Program; Leslie Lehmann, Dana Farber Cancer Institute; Boston Children's Hospital, Boston, MA; and Molly Moore, University of Vermont, Burlington, VT., Shulman LN; Fidel Rubagumya, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania; Mary Jue Xu, University of California, San Francisco, San Francisco, CA; Leana May, Children's Hospital Colorado, Aurora, CO; Caitlin Driscoll, Mount Sinai Medical School, New York, NY; Frank Regis Uwizeye, Cyprien Shyirambere, and Alexandra E. Fehr, Inshuti Mu Buzima/Partners In Health; Umuhizi Denis Gilbert, Clemence Muhayimana, Vedaste Hategekimana, and Tharcisse Mpunga, Ministry of Health, Kigali, Rwanda; Katherine Larrabee, Geisinger Commonwealth School of Medicine, Scranton; Lawrence N. Shulman, University of Pennsylvania, Philadelphia, PA; Shekinah Elmore, Harvard Radiation Oncology Program; Leslie Lehmann, Dana Farber Cancer Institute; Boston Children's Hospital, Boston, MA; and Molly Moore, University of Vermont, Burlington, VT., Lehmann L; Fidel Rubagumya, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania; Mary Jue Xu, University of California, San Francisco, San Francisco, CA; Leana May, Children's Hospital Colorado, Aurora, CO; Caitlin Driscoll, Mount Sinai Medical School, New York, NY; Frank Regis Uwizeye, Cyprien Shyirambere, and Alexandra E. Fehr, Inshuti Mu Buzima/Partners In Health; Umuhizi Denis Gilbert, Clemence Muhayimana, Vedaste Hategekimana, and Tharcisse Mpunga, Ministry of Health, Kigali, Rwanda; Katherine Larrabee, Geisinger Commonwealth School of Medicine, Scranton; Lawrence N. Shulman, University of Pennsylvania, Philadelphia, PA; Shekinah Elmore, Harvard Radiation Oncology Program; Leslie Lehmann, Dana Farber Cancer Institute; Boston Children's Hospital, Boston, MA; and Molly Moore, University of Vermont, Burlington, VT.
Publikováno v:
Journal of global oncology [J Glob Oncol] 2018 Sep; Vol. 4, pp. 1-11. Date of Electronic Publication: 2017 Oct 30.